BJDX
BJDX
NASDAQ · Health Care

Bluejay Diagnostics Inc

$1.96
-0.02 (-1.01%)
As of Mar 29, 11:05 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.48M
Net Income
82.9K
Gross Margin
49.4%
Profit Margin
5.6%
Rev Growth
+21.6%
D/E Ratio
1.01
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 49.4% 49.4% 49.4%
Operating Margin 5.4% 6.4% 5.7%
Profit Margin 5.6% 6.7% 5.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.48M 1.49M 1.30M
Gross Profit 731.7K 736.2K 641.4K
Operating Income 80.4K 95.6K 73.6K
Net Income 82.9K 99.7K 70.4K
Gross Margin 49.4% 49.4% 49.4%
Operating Margin 5.4% 6.4% 5.7%
Profit Margin 5.6% 6.7% 5.4%
Rev Growth +21.6% -6.7% +20.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.07M 981.3K 871.2K
Total Equity 1.06M 1.10M 1.01M
D/E Ratio 1.01 0.89 0.86
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 120.1K 112.7K 103.3K
Free Cash Flow 69.0K 73.7K 63.9K